- Home
- XBP vs TPST Comparison
XBP vs TPST Comparison
Compare XBP & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- TPST
- Stock Information
- Founded
- XBP N/A
- TPST 2011
- Country
- XBP United Kingdom
- TPST United States
- Employees
- XBP N/A
- TPST N/A
- Industry
- XBP Business Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- TPST Health Care
- Exchange
- XBP Nasdaq
- TPST Nasdaq
- Market Cap
- XBP 32.2M
- TPST 33.0M
- IPO Year
- XBP N/A
- TPST N/A
- Fundamental
- Price
- XBP $1.63
- TPST $7.54
- Analyst Decision
- XBP
- TPST Hold
- Analyst Count
- XBP 0
- TPST 3
- Target Price
- XBP N/A
- TPST $30.00
- AVG Volume (30 Days)
- XBP 7.5M
- TPST 94.0K
- Earning Date
- XBP 08-11-2025
- TPST 08-11-2025
- Dividend Yield
- XBP N/A
- TPST N/A
- EPS Growth
- XBP N/A
- TPST N/A
- EPS
- XBP N/A
- TPST N/A
- Revenue
- XBP $142,332,000.00
- TPST N/A
- Revenue This Year
- XBP N/A
- TPST N/A
- Revenue Next Year
- XBP N/A
- TPST N/A
- P/E Ratio
- XBP N/A
- TPST N/A
- Revenue Growth
- XBP N/A
- TPST N/A
- 52 Week Low
- XBP $0.79
- TPST $5.35
- 52 Week High
- XBP $2.56
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- XBP 83.00
- TPST 56.78
- Support Level
- XBP $0.85
- TPST $7.13
- Resistance Level
- XBP $0.95
- TPST $8.75
- Average True Range (ATR)
- XBP 0.16
- TPST 0.47
- MACD
- XBP 0.05
- TPST 0.12
- Stochastic Oscillator
- XBP 45.62
- TPST 54.17
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.